Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

BACKGROUND: Stage shift is widely considered a major determinant of the survival benefit conferred by breast cancer screening. However, factors and mechanisms underlying such a prognostic advantage need further clarification. We sought to compare the molecular characteristics of screen detected vs....

Descripción completa

Detalles Bibliográficos
Autores principales: Crispo, Anna, Barba, Maddalena, D’Aiuto, Giuseppe, De Laurentiis, Michelino, Grimaldi, Maria, Rinaldo, Massimo, Caolo, Giuseppina, D’Aiuto, Massimiliano, Capasso, Immacolata, Esposito, Emanuela, Amore, Alfonso, Di Bonito, Maurizio, Botti, Gerardo, Montella, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598199/
https://www.ncbi.nlm.nih.gov/pubmed/23305429
http://dx.doi.org/10.1186/1471-2407-13-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598199/
https://www.ncbi.nlm.nih.gov/pubmed/23305429
http://dx.doi.org/10.1186/1471-2407-13-15

Ejemplares similares